177 related articles for article (PubMed ID: 19653042)
1. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.
Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G
Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
5. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer.
Huo Q; Kinugasa T; Wang L; Huang J; Zhao J; Shibaguchi H; Kuroki M; Tanaka T; Yamashita Y; Nabeshima K; Iwasaki H; Kuroki M
Anticancer Res; 2009 Mar; 29(3):851-7. PubMed ID: 19414319
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.
Gessi S; Cattabriga E; Avitabile A; Gafa' R; Lanza G; Cavazzini L; Bianchi N; Gambari R; Feo C; Liboni A; Gullini S; Leung E; Mac-Lennan S; Borea PA
Clin Cancer Res; 2004 Sep; 10(17):5895-901. PubMed ID: 15355922
[TBL] [Abstract][Full Text] [Related]
9. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
10. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
11. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
14. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
[TBL] [Abstract][Full Text] [Related]
15. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
16. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.
Williams CJ; Mitsiades N; Sozopoulos E; Hsi A; Wolk A; Nifli AP; Tseleni-Balafouta S; Mantzoros CS
Endocr Relat Cancer; 2008 Mar; 15(1):289-99. PubMed ID: 18310295
[TBL] [Abstract][Full Text] [Related]
18. Significance of p-STAT3 expression in human colorectal adenocarcinoma.
Park JK; Hong R; Kim KJ; Lee TB; Lim SC
Oncol Rep; 2008 Sep; 20(3):597-604. PubMed ID: 18695911
[TBL] [Abstract][Full Text] [Related]
19. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
